The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas
Status:
Terminated
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This study will compare two different models of a wearable bionic pancreas device (the
iPhone-based bionic pancreas vs. the iLet bionic pancreas) in adult participant with type 1
diabetes. Both bionic pancreas devices measure glucose levels every five minutes and then
give insulin and/or glucagon automatically to regulate the blood glucose (BG).